Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
BVI® launches CryoTreq®, a single-use handheld cryo-surgery device to revolutionize treatment of retinal tears and detachments: | ||
By: PR Newswire Association LLC. - 04 Jun 2020 | Back to overview list |
|
WALTHAM, Mass., June 3, 2020 /PRNewswire/ -- BVI, the fastest growing diversified company in ophthalmology, today announced the European launch of CryoTreq – the world's first single-use, handheld cryo-surgery device for ophthalmology. The product was developed in partnership with Prof. Stanislao Rizzo*, a retinal surgeon and Professor at University of Florence. This stand-alone device for cryo-surgery, functions without external connections to equipment, gas tanks or power and does not require any service or maintenance. During the last few years, CryoTreq has been developed to modernize a well-proven method for treating sight-threatening retinal tears and detachments. "Within a minute of opening the sterile blister I am ready to treat retinal tears or detachment, whether I'm in my office or in the operating room. It's never been this easy to perform a cryo procedure", said Prof. Stanislao Rizzo from Italy. CryoTreq enables a minimally invasive ab externo approach to treat retinal tears and detachments, providing an alternative to laser photocoagulation – especially for lesions located towards the anterior of the eye. It requires minimal time for preparation, is easy and intuitive to use, with a hand-controlled single button activation. Like existing cryo equipment CryoTreq's probe reaches temperatures as low as -88?C and the tip reaches cryogenic temperatures within 4 to 6 seconds after activation. The launch will complement BVI's existing posterior ophthalmic surgery portfolio, which includes high-quality and innovative single-use instruments, tamponades, dyes, enriched sterile saline solution and surgical equipment. "CryoTreq will be a game changer. The ease of use and efficiency will make cryo-surgery accessible to more surgeons and their patients. We believe surgeons will, over time, replace use of many laser-based procedures with CryoTreq as well", according to Shervin Korangy, BVI President and CEO. BVI is actively working on registrations in jurisdictions outside of Europe. *Prof. Stanislao Rizzo has no financial interest related to CryoTreq, BVI and Vitreq. About BVI Contact: View original content to download multimedia:http://www.prnewswire.com/news-releases/bvi-launches-cryotreq-a-single-use-handheld-cryo-surgery-device-to-revolutionize-treatment-of-retinal-tears-and-detachments-301070443.html SOURCE BVI |
||
|
||
Copyright 2020 PR Newswire Association LLC. | Back to overview list |